About BioSignal Analytics
BioSignal Analytics is dedicated to improving the quality of healthcare through the use of automated interpretation technology based on state of the art machine learning algorithms. We leverage big data resources to train sophisticated models capable of self-organizing unstructured data and discovering underlying structure. Our initial product, AutoEEG, leverages validated deep learning techniques and the world’s largest EEG corpus to achieve unprecedented performance in automated EEG analysis. Initial applications include real-time seizure detection for long-term monitoring studies in epilepsy monitoring units and intensive care units to improve patient outcomes and increase access to care. BioSignal Analytics is a portfolio company of Phase 1 Ventures.
|
|
|
11-50 employees
View all BioSignal Analytics employees
|
|
Medical Equipment Manufacturing
|
|
2015
|
BioSignal Analytics Alternatives
Frequently Asked Questions about BioSignal Analytics
Amir Harati is the CEO of BioSignal Analytics. To contact Amir Harati email at [email protected] or [email protected].
Search BioSignal Analytics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
